Author: Arepally, Gowthami M; Ortel, Thomas L; Arepally, GM; Ortel, TL
Title: Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Cord-id: o0kvmgqb Document date: 2021_7_29
ID: o0kvmgqb
Snippet: The development of vaccines to fight COVID-19 has been a remarkable medical achievement. However, this global immunization effort has been complicated by a rare vaccine-related outcome characterized by thrombocytopenia and thrombosis in association with platelet-activating anti-platelet factor 4 antibodies. In this Spotlight, we will discuss the recently described complication of vaccine-induced immune thrombotic thrombocytopenia (VITT) occurring in response to certain COVID-19 vaccines. Althoug
Document: The development of vaccines to fight COVID-19 has been a remarkable medical achievement. However, this global immunization effort has been complicated by a rare vaccine-related outcome characterized by thrombocytopenia and thrombosis in association with platelet-activating anti-platelet factor 4 antibodies. In this Spotlight, we will discuss the recently described complication of vaccine-induced immune thrombotic thrombocytopenia (VITT) occurring in response to certain COVID-19 vaccines. Although information about this clinical condition is rapidly evolving, we will summarize our current understanding of VITT.
Search related documents:
Co phrase search for related documents- abdominal pain and acid ribonucleic: 1, 2
- abdominal pain and long term outcome: 1, 2, 3
- abdominal pain vomiting and absence presence: 1, 2, 3, 4
- abdominal pain vomiting and acid ribonucleic: 1
- abdominal pain vomiting nausea and absence presence: 1, 2
- abdominal pain vomiting nausea and acid ribonucleic: 1
- absence presence and acid ribonucleic: 1, 2
- acid ribonucleic and adenovirus vector: 1, 2
Co phrase search for related documents, hyperlinks ordered by date